scholarly journals Side Effects of Pfizer-BioNTech COVID-19 Vaccine among Libyan Young Adults: Observational Study

2022 ◽  
Vol 10 (01) ◽  
pp. 33-45
Author(s):  
Taher I. Shailabi ◽  
Elham O. Borwis ◽  
Nisreen Saed Majeed ◽  
Nagat H. Bubtina ◽  
Naeima Betamar ◽  
...  
2019 ◽  
pp. 150-151
Author(s):  
David L. Brody

New onset hallucinations and delusions are rare after isolated concussion and should trigger a search for other causes: Schizophrenia (relatively common in young adults), drug abuse, alcohol or drug withdrawal, and delirium due to infection or sleep deprivation should be considered. Importantly, if the psychosis is dangerous or potentially dangerous, think about safety first. This may require inpatient admission to a psychiatric service. If outpatient treatment is required, atypical antipsychotics should be used in as low a dose as possible to minimize cognitive side effects. Aripiprazole (Abilify) is associated with less weight gain than other atypical antipsychotics. Risperidone (Risperdal) is the least expensive. Quetiapine (Seroquel), or rarely Clozaril, are the best choices when parkinsonism is a comorbidity.


2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Deborah T. Gold ◽  
David L. Weinstein ◽  
Gerhardt Pohl ◽  
Kelly D. Krohn ◽  
Yi Chen ◽  
...  

Purpose. Determine patient-reported reasons for discontinuation with teriparatide.Methods. Patients taking teriparatide in a multicenter, prospective, and observational study were given three questionnaires: baseline, follow-up questionnaire 1 (QF1, 2 to 6 months), and follow-up questionnaire 2 (QF2, 12 months). Discontinuation reported at QF1 and QF2 was defined as “early” and “late,” respectively, and remaining patients were considered persistent. Cochran-Armitage trend test was used to identify factors associated with discontinuation.Results. Side effects, concern about improper use, injection difficulties, and several patient-perceived physician issues were associated with early discontinuation. Low patient-perceived importance of continuing treatment, side effects, difficulty paying, and low patient-perceived physician knowledge were associated with late discontinuation. The most common specific reasons selected for discontinuing treatment were “concerns about treatment outweighing the benefits” (n=53) and “difficulty paying” (n=47).Conclusions. Persistence with teriparatide is dependent on managing side effects, addressing financial challenges, proper training, and obtaining support from the healthcare provider.


Epilepsia ◽  
2019 ◽  
Vol 60 (11) ◽  
pp. 2255-2262 ◽  
Author(s):  
Anna Rosati ◽  
Alessandra Boncristiano ◽  
Viola Doccini ◽  
Alessandra Pugi ◽  
Tiziana Pisano ◽  
...  

2018 ◽  
Vol 50 (4) ◽  
pp. e391
Author(s):  
A. Corsello ◽  
D. Pugliese ◽  
F. Bracci ◽  
D. Knafelz ◽  
B. Papadatou ◽  
...  

2019 ◽  
Vol 32 (2) ◽  
pp. 250-257 ◽  
Author(s):  
Julia Crilly ◽  
Jamie Ranse ◽  
Nerolie Bost ◽  
Tonya Donnelly ◽  
Jo Timms ◽  
...  

2013 ◽  
Vol 13 (2) ◽  
pp. 139-150 ◽  
Author(s):  
Stefania Russo ◽  
Marika Cinausero ◽  
Lorenzo Gerratana ◽  
Claudia Bozza ◽  
Donatella Iacono ◽  
...  

2010 ◽  
Vol 17 (4) ◽  
pp. 304-311 ◽  
Author(s):  
Ioanna Saratsiotou ◽  
Maria Kordoni ◽  
Charalampos Bakogiannis ◽  
Eleftheria Livadarou ◽  
Dimosthenis Skarlos ◽  
...  

Purpose. The aim of this prospective observational study was to investigate the patterns of treatment adherence to orally administered chemotherapy of patients being treated for cancer. Methods. Patients were asked to participate in the survey during their visits to the study centers’ pharmacists or doctors to obtain their oral medication from April 2008 until May 2009. The data were collected using a self-reported anonymous 7-page long questionnaire, which contained questions about their demographic profile, disease and treatment characteristics, and side-effects and adherence information, both intentional and nonintentional. Results. 99 Patients completed the questionnaire. Missing values ranged from 1% to 8%. Unintended nonadherence to therapy was reported by 19 patients. The most important factor correlating with unintended nonadherence was the patient’s belief regarding treatment effectiveness since only 16.7% of the patients believing that their treatment is effective reported nonadherence as opposed to 62.5% for those that did not believe that treatment is effective ( p = 0.03). Intentional nonadherence was reported by 14 patients The most important factor correlating to intentional nonadherence was time since disease diagnosis, as nonadherence was reported by 33.3% of the patients having the disease less than 6 months, compared to 16.7% for those between 6 and 24 months and 8.3% for those between 2 and 5 years ( p = 0.01). Conclusion. Greek patients seem to have similar nonadherence pattern as in other countries. Confidence in treatment efficacy appeared as a significant adherence determinant.


Sign in / Sign up

Export Citation Format

Share Document